On the priority of intellectual property rights, especially in biotechnology

This article argues that considerations about the role and predictability of intellectual innovation make the protection of intellectual property morally obligatory even when it greatly reduces short-term welfare. Since the provision of good new ideas is the only productive input not subject to decreasing marginal productivity, welfarist considerations require that no impediment to its maximal provision be erected and the potentially substantial welfare losses imposed by a patent system be mitigated by taxation of other sources of wealth and income. Key Words: patent system • welfarism • decreasing marginal productivity.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1177/1470594X04039983
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
Download options
PhilPapers Archive

Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 22,631
External links
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library
References found in this work BETA

No references found.

Add more references

Citations of this work BETA
Tom Andreassen (2015). Patent Funded Access to Medicines. Developing World Bioethics 15 (3):152-161.

Add more citations

Similar books and articles

Monthly downloads

Added to index


Total downloads

50 ( #90,667 of 1,938,720 )

Recent downloads (6 months)

7 ( #83,335 of 1,938,720 )

How can I increase my downloads?

My notes
Sign in to use this feature

Start a new thread
There  are no threads in this forum
Nothing in this forum yet.